[Campylobacter enteritis and related organisms. Clinical microbiology and antibiotic resistance].
The Authors underline the importance to always and correctly investigate also for Campylobacters and related organisms (Clo's) in faeces of humans with enteritis, because prevalent like Salmonella and for surveillance antibiotic resistances; in fact for campylobacteriosis specific therapy is often necessary. Between 2001 and 2005 248 strains of Campylobacter and Clo's were isolated: 225 were C. jejuni (90.7%) and 16 C. coli (6.5%). The recommended antibiotics to use for therapy, for preventing secondary effects too, are erythromycin, ciprofloxacin and tetracycline. Among C. jejuni, resistances towards erithromycine were 6.8% during 2001-02, 6.8% during 2003 and 4.8% during 2004-05; the resistances towards ciprofloxacin were 52.9% during 2001-02, 53.8% during 2003 and 42.9% during 2004-05; the resistances towards tetracycline were 39.2% during 2001-02, 46.2% during 2003 and 50.0% during 2004-05. The strains of C. coli showed less resistances, also in respect of previous our data too. No relevant differences were observed in antibacterial resistances among strains isolated from children and strains isolated from adults.
Crotti
Daniele
D
Libero professionista in Parassitologia e Microbiologia Medica, Perugia. nenedc@tin.it
D'Annibale
Maria Letizia
ML
D000328:Adult; D002169:Campylobacter Infections / Q000188:drug therapy*; D002648:Child; D024881:Drug Resistance, Bacterial; D004751:Enteritis / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans